Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Diaz

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 6, 2018
Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysisMatthew N Mills, George Q Yang, Daniel E Oliver, et al.
The Oncologist|September 13, 2021
Increased Risk for Ipsilateral Breast Tumor Recurrence in Invasive Lobular Carcinoma after Accelerated Partial Breast Irradiation BrachytherapyMatthew N Mills, Nicholas W Russo, Matthew Fahey, et al.
Breast Cancer Research and Treatment|February 3, 2018
Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experienceNicholas B Figura, Wendy Long, Michael Yu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2007
Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancerJeffrey M Albert, Adriana Gonzalez, Pierre P Massion, et al.
Neurosurgical Review|February 4, 2026
A pilot comparative study of intraoperative results and surgical outcomes between asleep-awake-asleep and general anesthesia modalities in temporal lobe resectionsDaniel San-Juan, Roberto Diaz-Peregrino, Alfonso Arellano-Reynoso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab as the Upfront Treatment in Patients With Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS)Javier Martin-Broto, Roberto Diaz-Beveridge, David Moura, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2009
Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancerRoberto Diaz, Jerry J Jaboin, Manuel Morales-Paliza, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|July 22, 2022
Need of vascular surgeon and comparison of value for anterior lumbar interbody fusion (ALIF) in lateral decubitus: Delphi consensusCristiano Magalhães Menezes, Todd Alamin, Rodrigo Amaral, et al.
Clinical Breast Cancer|August 13, 2021
MRI Response to Pre-operative Stereotactic Ablative Body Radiotherapy (SABR) in Early Stage ER/PR+ HER2- Breast Cancer correlates with Surgical Pathology Tumor Bed CellularityR Jared Weinfurtner, Natarajan Raghunand, Olya Stringfield, et al.
Frontiers in Oncology|January 30, 2019
Is Proton Therapy a "Pro" for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer DatabaseMudit Chowdhary, Anna Lee, Sarah Gao, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
European Journal of Cancer (Oxford, England : 1990)|June 6, 2018
Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysisMatthew N Mills, George Q Yang, Daniel E Oliver, et al.
The Oncologist|September 13, 2021
Increased Risk for Ipsilateral Breast Tumor Recurrence in Invasive Lobular Carcinoma after Accelerated Partial Breast Irradiation BrachytherapyMatthew N Mills, Nicholas W Russo, Matthew Fahey, et al.
Breast Cancer Research and Treatment|February 3, 2018
Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experienceNicholas B Figura, Wendy Long, Michael Yu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2007
Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancerJeffrey M Albert, Adriana Gonzalez, Pierre P Massion, et al.
Neurosurgical Review|February 4, 2026
A pilot comparative study of intraoperative results and surgical outcomes between asleep-awake-asleep and general anesthesia modalities in temporal lobe resectionsDaniel San-Juan, Roberto Diaz-Peregrino, Alfonso Arellano-Reynoso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab as the Upfront Treatment in Patients With Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS)Javier Martin-Broto, Roberto Diaz-Beveridge, David Moura, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2009
Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancerRoberto Diaz, Jerry J Jaboin, Manuel Morales-Paliza, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|July 22, 2022
Need of vascular surgeon and comparison of value for anterior lumbar interbody fusion (ALIF) in lateral decubitus: Delphi consensusCristiano Magalhães Menezes, Todd Alamin, Rodrigo Amaral, et al.
Clinical Breast Cancer|August 13, 2021
MRI Response to Pre-operative Stereotactic Ablative Body Radiotherapy (SABR) in Early Stage ER/PR+ HER2- Breast Cancer correlates with Surgical Pathology Tumor Bed CellularityR Jared Weinfurtner, Natarajan Raghunand, Olya Stringfield, et al.
Frontiers in Oncology|January 30, 2019
Is Proton Therapy a "Pro" for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer DatabaseMudit Chowdhary, Anna Lee, Sarah Gao, et al.
Pageof 12